Sinocelltech Group Limited (SHA:688520)
42.29
-0.58 (-1.35%)
May 8, 2026, 3:00 PM CST
Sinocelltech Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,364 | 1,560 | 2,512 | 1,887 | 1,023 | 134.39 |
Other Revenue | - | - | 0.61 | - | - | - |
| 1,364 | 1,560 | 2,513 | 1,887 | 1,023 | 134.39 | |
Revenue Growth (YoY) | -43.65% | -37.91% | 33.13% | 84.46% | 661.33% | 40852.82% |
Cost of Revenue | 114.76 | 107.68 | 121.27 | 107.3 | 38.72 | 15.8 |
Gross Profit | 1,249 | 1,452 | 2,391 | 1,780 | 984.45 | 118.59 |
Selling, General & Admin | 1,013 | 1,030 | 881.63 | 584.1 | 395.32 | 247.12 |
Research & Development | 831.44 | 837.85 | 903.65 | 1,139 | 882.13 | 725.57 |
Other Operating Expenses | -76.44 | -78.17 | 16.22 | 12.94 | 9.07 | 3.97 |
Operating Expenses | 1,768 | 1,790 | 1,804 | 1,738 | 1,290 | 977.42 |
Operating Income | -519.02 | -337.49 | 587.9 | 42.53 | -305.07 | -858.83 |
Interest Expense | - | - | -103.55 | -111.52 | -84.47 | -33.73 |
Interest & Investment Income | 1.5 | 1.25 | 5.15 | 9.51 | 9.75 | 14.45 |
Currency Exchange Gain (Loss) | - | - | -0.14 | -3.56 | -7.07 | 0.22 |
Other Non Operating Income (Expenses) | -276.14 | -218.07 | -1.67 | -0.19 | -0.15 | -0.15 |
EBT Excluding Unusual Items | -793.66 | -554.31 | 487.69 | -63.23 | -387 | -878.04 |
Gain (Loss) on Sale of Investments | 9.22 | 10.32 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | -0.3 | -0.18 | -0.08 | -0.02 |
Asset Writedown | -24.7 | -19.64 | - | - | - | - |
Other Unusual Items | - | - | -375.03 | -333.42 | -132.97 | 9.2 |
Pretax Income | -809.14 | -563.62 | 112.35 | -396.83 | -520.05 | -868.87 |
Income Tax Expense | 2.29 | 2.58 | - | - | - | - |
Earnings From Continuing Operations | -811.43 | -566.2 | 112.35 | -396.83 | -520.05 | -868.87 |
Minority Interest in Earnings | 7.12 | 1.35 | -0.4 | 0.81 | 1.06 | 2.02 |
Net Income | -804.31 | -564.85 | 111.95 | -396.02 | -519 | -866.85 |
Net Income to Common | -804.31 | -564.85 | 111.95 | -396.02 | -519 | -866.85 |
Shares Outstanding (Basic) | 412 | 428 | 466 | 445 | 436 | 436 |
Shares Outstanding (Diluted) | 412 | 428 | 466 | 445 | 436 | 436 |
Shares Change (YoY) | -14.08% | -8.26% | 4.83% | 2.02% | 0.12% | 6.38% |
EPS (Basic) | -1.95 | -1.32 | 0.24 | -0.89 | -1.19 | -1.99 |
EPS (Diluted) | -1.95 | -1.32 | 0.24 | -0.89 | -1.19 | -1.99 |
Free Cash Flow | -516.11 | -492.12 | -250.5 | -888.75 | -982.71 | -1,057 |
Free Cash Flow Per Share | -1.25 | -1.15 | -0.54 | -2.00 | -2.25 | -2.43 |
Gross Margin | 91.58% | 93.10% | 95.17% | 94.31% | 96.21% | 88.24% |
Operating Margin | -38.06% | -21.63% | 23.40% | 2.25% | -29.82% | -639.04% |
Profit Margin | -58.98% | -36.20% | 4.46% | -20.98% | -50.72% | -645.01% |
Free Cash Flow Margin | -37.85% | -31.54% | -9.97% | -47.09% | -96.05% | -786.26% |
EBITDA | -355.96 | -182.64 | 709.9 | 136.98 | -248.25 | -814.58 |
EBITDA Margin | -26.10% | -11.71% | 28.25% | 7.26% | -24.26% | - |
D&A For EBITDA | 163.07 | 154.85 | 122 | 94.45 | 56.82 | 44.25 |
EBIT | -519.02 | -337.49 | 587.9 | 42.53 | -305.07 | -858.83 |
EBIT Margin | -38.06% | -21.63% | 23.40% | 2.25% | -29.82% | - |
Revenue as Reported | - | - | 2,513 | 1,887 | 1,023 | 134.39 |
Advertising Expenses | - | - | 301.73 | 125.29 | 65.56 | 27.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.